Patent details
EP4129290 Title: PHARMACEUTICAL COMPOSITION COMPRISING PYRONARIDINE OR A SALT THEREOF, ARTEMISININ OR A DERIVATIVE THEREOF OR A COMBINATION OF BOTH FOR PREVENTING OR TREATING A RESPIRATORY DISEASE CAUSED BY A CORONAVIRUS
Basic Information
- Publication number:
- EP4129290
- PCT Application Number:
- KR2021003742
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP217752310
- PCT Publication Number:
- WO2021194290
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITION COMPRISING PYRONARIDINE OR A SALT THEREOF, ARTEMISININ OR A DERIVATIVE THEREOF OR A COMBINATION OF BOTH FOR PREVENTING OR TREATING A RESPIRATORY DISEASE CAUSED BY A CORONAVIRUS
- French Title of Invention:
- COMPOSITION PHARMACEUTIQUE COMPRENANT DE LA PYRONARYIDINE OU UN SEL DE CELLE-CI, DE L'ARTÉMISININE OU UN DÉRIVÉ DE CELLE-CI OU UNE COMBINAISON DES DEUX POUR PRÉVENIR OU TRAITER UNE MALADIE RESPIRATOIRE PROVOQUÉE PAR UN CORONAVIRUS
- German Title of Invention:
- PHARMAZEUTISCHE ZUBEREITUNG, UMFASSEND PYRONARIDIN ODER EIN SALZ DAVON, ARTEMISININ ODER EIN DERIVAT DAVON ODER EINE KOMBINATION VON BEIDEN, ZUR VORBEUGUNG ODER BEHANDLUNG EINER DURCH EIN CORONAVIRUS VERURSACHTEN RESPIRATORISCHEN ERKRANKUNG
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 08/08/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 21/08/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 09/07/2025
- Unitary Effect Registration Date:
- 21/08/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 25/03/2021
- Grant date:
- 09/07/2025
- EP Publication Date:
- 08/02/2023
- PCT Publication Date:
- 30/09/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/07/2025
- EP B1 Publication Date:
- 09/07/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 25/03/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/07/2025
- Name:
- Shin Poong Pharmaceutical Co., Ltd.
- Address:
- 7 Wonsi-ro Danwon-gu, Ansan-si, Gyeonggi-do 15610, Korea (Republic) (KR)
Inventor
1
- Name:
- RYU, Jei Man
- Address:
- Korea (Republic) (KR)
2
- Name:
- CHO, Geum Sil
- Address:
- Korea (Republic) (KR)
3
- Name:
- CHUNG, Hyun Kyu
- Address:
- Korea (Republic) (KR)
4
- Name:
- JU, Chung
- Address:
- Korea (Republic) (KR)
Priority
- Priority Number:
- 20200037135
- Priority Date:
- 26/03/2020
- Priority Country:
- Korea (Republic) (KR)
Classification
- IPC classification:
- A61K 31/4738; A61K 31/37; A61K 31/7056; A61K 38/21; A61K 31/167; A61K 45/06; A61P 31/14; A61K 31/4745; A61K 31/609; A61K 31/357; A61K 31/366;
Publication
European Patent Bulletin
1
- Issue number:
- 202528
- Publication date:
- 09/07/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202538
- Publication date:
- 17/09/2025
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202539
- Publication date:
- 24/09/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|